These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 21806385)

  • 1. Association of genetic variants in six candidate genes with valproic acid therapy optimization.
    Hung CC; Ho JL; Chang WL; Tai JJ; Hsieh TJ; Hsieh YW; Liou HH
    Pharmacogenomics; 2011 Aug; 12(8):1107-17. PubMed ID: 21806385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization.
    Hung CC; Chang WL; Ho JL; Tai JJ; Hsieh TJ; Huang HC; Hsieh YW; Liou HH
    Pharmacogenomics; 2012 Jan; 13(2):159-69. PubMed ID: 22188362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early post-traumatic seizures are associated with valproic acid plasma concentrations and UGT1A6/CYP2C9 genetic polymorphisms in patients with severe traumatic brain injury.
    Sun Y; Yu J; Yuan Q; Wu X; Wu X; Hu J
    Scand J Trauma Resusc Emerg Med; 2017 Aug; 25(1):85. PubMed ID: 28841884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of uridine diphosphate glucuronosyltransferase 2B7 -161C>T polymorphism on the concentration of valproic acid in pediatric epilepsy patients.
    Inoue K; Suzuki E; Yazawa R; Yamamoto Y; Takahashi T; Takahashi Y; Imai K; Koyama S; Inoue Y; Tsuji D; Hayashi H; Itoh K
    Ther Drug Monit; 2014 Jun; 36(3):406-9. PubMed ID: 24365988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution pattern of UGT1A6 and UGT2B7 gene polymorphism and its impact on the pharmacokinetics of valproic acid and carbamazepine: Prospective genetic association study conducted in Pakistani patients with epilepsy.
    Saleh Faisal M; Jamil A; Ali N; Alshahrani AM; Almarshad F
    Gene; 2024 Jan; 892():147886. PubMed ID: 37820941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of UGT2B7 genetic variants on serum valproic acid concentration.
    Ma H; Zhang T; Gong Z; Zhou B; Zou M; Xiao S; Zhu W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 38(8):766-72. PubMed ID: 23981985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of MCT1 and ABCC2 gene polymorphisms with valproic acid resistance in patients with epilepsy on valproic acid monotherapy.
    Chen J; Su Q; Qin J; Zhou Y; Ruan H; Chen Z; Chen Z; Li H; Zhou Y; Zhou S; Wang X; Zhou L; Huang M
    Drug Metab Pharmacokinet; 2019 Jun; 34(3):165-171. PubMed ID: 30952578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of UGT2B7 Genetic Polymorphisms on Serum Concentrations of Valproic Acid in Chinese Children With Epilepsy Comedicated With Lamotrigine.
    Wang Q; Zhao L; Liang M; Dong Y; Yun W; Qiu F; Meng H; Guo Y
    Ther Drug Monit; 2016 Jun; 38(3):343-9. PubMed ID: 26717295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis.
    Wang P; Lin XQ; Cai WK; Xu GL; Zhou MD; Yang M; He GH
    Eur J Clin Pharmacol; 2018 Apr; 74(4):433-442. PubMed ID: 29243113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients.
    Chu XM; Zhang LF; Wang GJ; Zhang SN; Zhou JH; Hao HP
    Eur J Clin Pharmacol; 2012 Oct; 68(10):1395-401. PubMed ID: 22476391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
    Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A
    Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of the influence of UGT1A6 genetic polymorphisms on valproic acid pharmacokinetics
.
    Kim SC; Kim MG
    Int J Clin Pharmacol Ther; 2019 Mar; 57(3):144-151. PubMed ID: 30686291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of CYP2C9 and CYP2A6 Polymorphisms with the Concentrations of Valproate and its Hepatotoxin Metabolites and Valproate-Induced Hepatotoxicity.
    Zhao M; Zhang T; Li G; Qiu F; Sun Y; Zhao L
    Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):138-143. PubMed ID: 28273397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of UGT2B7 genotype on valproic acid pharmacokinetics in Chinese epilepsy patients.
    Sun YX; Zhuo WY; Lin H; Peng ZK; Wang HM; Huang HW; Luo YH; Tang FQ
    Epilepsy Res; 2015 Aug; 114():78-80. PubMed ID: 26088889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy.
    Guo Y; Hu C; He X; Qiu F; Zhao L
    Drug Metab Pharmacokinet; 2012; 27(5):536-42. PubMed ID: 23099353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Age and Genotype on Serum Concentrations of Valproic Acid and Its Hepatotoxic Metabolites in Chinese Pediatric Patients With Epilepsy.
    Zhao M; Chen Y; Wang M; Li G; Zhao L
    Ther Drug Monit; 2020 Oct; 42(5):760-765. PubMed ID: 32107351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of MDR1 and UGT Gene Polymorphisms on Sodium Valproate Plasma Concentration in Patients with Epilepsy.
    Song C; Li X; Zhang H; Bao J; Lu W; Peng Q; Zhang Y
    Clin Lab; 2022 Oct; 68(10):. PubMed ID: 36250837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Valproic Acid-induced Hyperammonaemia in Chinese Paediatric Patients with Epilepsy.
    Zhu X; Li X; Zhang T; Zhao L
    Basic Clin Pharmacol Toxicol; 2018 Nov; 123(5):628-634. PubMed ID: 29791065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCC2 rs2273697 is associated with valproic acid concentrations in patients with epilepsy on valproic acid monotherapy.
    Chen J; Su QB; Tao YQ; Qin JM; Zhou Y; Zhou S; Li HL; Chen ZJ; Zhou YF; Zhou LM; Wang XD; Huang M
    Pharmazie; 2018 May; 73(5):279-282. PubMed ID: 29724294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between ABCB1 polymorphism and response to sodium valproate treatment in Malaysian epilepsy patients.
    Haerian BS; Lim KS; Tan HJ; Mohamed EH; Tan CT; Raymond AA; Wong CP; Wong SW; Omar H; Roslan H; Mohamed Z
    Epileptic Disord; 2011 Mar; 13(1):65-75. PubMed ID: 21388909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.